Idexx Laboratories Inc
IDEXX Laboratories, Inc., is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500 ® Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories.
Net income compounded at 16.3% annually over 6 years.
Current Price
$569.55
+0.87%GoodMoat Value
$374.04
34.3% overvaluedIdexx Laboratories Inc (IDXX) DCF Calculator
What is a DCF Calculator?
A Discounted Cash Flow (DCF) model estimates a company's intrinsic value by projecting its future cash flows and discounting them back to the present. The core idea: a dollar earned in the future is worth less than a dollar today.
Inputs
Cash flow, discount rate, terminal growth & projection years
Model
Projects cash flows forward, adds terminal value, discounts back
Output
Intrinsic value per share — compare with price for margin of safety
Enter a ticker on the left to auto-fill real financial data and get started.
IDXX DCF Calculator — Discounted Cash Flow
Discounted Cash Flow (DCF) calculator for Idexx Laboratories Inc (IDXX). Estimate the intrinsic value of IDXX stock by projecting future cash flows and discounting them to present value. The two-stage DCF model supports EPS-based, FCF-based, and dividend-based approaches.
Current EPS: $13.08. Free cash flow: $1.04B. FCF growth rate: 22.81%. WACC: 10.00%. Shares outstanding: 79.9M. GoodMoat fair value: $374.04.
The DCF calculator projects 10 years of cash flows at a user-adjustable growth rate, applies a terminal growth rate, and discounts all future cash flows back to present value using the weighted average cost of capital (WACC). A sensitivity table shows how the intrinsic value changes across different growth and discount rate assumptions. Use this tool alongside GoodMoat's reverse DCF and fair value models to triangulateIdexx Laboratories Inc's true worth.